Bicara Therapeutics Inc. Common Stock (BCAX) vs Innovage Holding Corp. (INNV)

A side-by-side comparison of Bicara Therapeutics Inc. Common Stock and Innovage Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bicara Therapeutics Inc. Common Stock logo
BCAX
Bicara Therapeutics Inc. Common Stock
$1.12B
$17.05HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Innovage Holding Corp. logo
INNV
Innovage Holding Corp.
$1.23B
$9.08HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — BCAX vs INNV

growth of $100 · dividends reinvested · last 2y
BCAX -26.1% (-14.1%/yr)INNV +50.3% (+22.6%/yr)INNV compounded faster over this window
50100150200Start $10020252026$74$150
BCAX INNV

BCAX vs INNV: by the numbers

  • •INNV is the larger company ($1.23B vs $1.12B market cap).
  • •Both run net losses; BCAX's is the smaller (0.00% vs -0.26% net margin).

Metrics side by side

Valuation

MetricBCAXINNV
Forward P/EN/A20.62
P/S ratioN/A1.25
P/B ratio2.395.23
EV / EBITDAN/A14.48
FCF yieldN/A4.10%

Profitability

MetricBCAXINNV
Gross margin0.00%21.39%
Operating margin0.00%6.39%
Net margin0.00%-0.26%
ROE-39.54%-1.08%
ROIC-42.98%9.48%

Growth (annualized)

MetricBCAXINNV
Revenue CAGR (5Y)N/A9.19%
Total return CAGR (5Y)N/A5.55%

Go deeper

Full BCAX analysisFull INNV analysisInteractive comparison tool

Dig into the metrics

Bicara Therapeutics Inc. Common Stock ROEInnovage ROEBicara Therapeutics Inc. Common Stock operating marginInnovage operating marginBicara Therapeutics Inc. Common Stock revenue growthInnovage revenue growthBicara Therapeutics Inc. Common Stock free cash flowInnovage free cash flow

Bicara Therapeutics Inc. Common Stock & Innovage appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.